Malaysia Results Review
18 August 2025
Affin (ABANK MK)
Solid 1H25, But Risks To Guidance Linger
Financial Services | Banks
Neutral (Maintained)
Target Price (Return): | MYR2.55 (+6%) |
---|---|
Price (Market Cap): | MYR2.40 (USD1,444m) |
ESG score: | 3.2 (out of 4) |
Avg Daily Turnover (MYR/USD) | 3.75m/0.86m |
Analysts
Nabil Thoo
+603 2302 8123
nabil.thoo@rhbgroup.com
David Chong CFA
+603 2302 8106
david.chongvc@rhbgroup.com
Share Performance (%)
YTD | 1m | 3m | 6m | 12m | |
---|---|---|---|---|---|
Absolute | (13.0) | (9.4) | (10.1) | (8.2) | (18.5) |
Relative | (9.3) | (13.0) | (10.6) | (7.5) | (16.5) |
52-wk Price low/high (MYR) | 2.27-3.25 |
Affin (ABANK MK)
Chart description: Price Close (MYR) from 2.3 to 3.5, and Relative to FBM KLCI (RHS) from 84 to 114, showing trends from Aug-24 to Aug-25.
Source: Bloomberg
- Keep NEUTRAL, with new MYR2.55 TP from MYR2.45, 6% upside and c.4% FY26F yield. While Affin’s 1H25 net profit came in at 54% of our full-year estimates, we deem the results to be broadly in line, as we anticipate a softer 2H25 from July’s policy rate cut. Management is also reviewing its FY25 guidance, with risks of downward revisions to loans growth and ROE targets. We suspect there will be minimal market reaction as investor focus shifts to FY26F, though we still prefer defensive, higher-yielding banks for now.
- Results review. Affin’s 2Q25 net profit of MYR143m (+21% YoY, +16% QoQ) brought the 1H25 sum to MYR268m (+17% YoY) – this formed 54% and 47% of our and consensus full-year estimates. Total income in 1H25 surged 16% YoY thanks to strong NII (+17% YoY on +7% loans growth and a +5bps NIM expansion) and non-II (+14% YoY on investment and forex gains). Opex grew by a softer clip of 7% YoY, and thus, the CIR reduced to 69% (1H24: 75%). 1H25 saw a return to more normalised credit cost levels of 14bps (1H24: net write-back), but all in, reported 1H25 ROAE of 4.5% was still an improvement from the 4.1% recorded in 1H24.
- Balance sheet highlights. Loans continued its above-industry momentum, growing 7% YoY (QoQ: +2%) – key drivers were community banking (+11% YoY from mortgages and personal finance) and enterprise banking (+15% YoY). LDR eased to 93% in 2Q25 (1Q25: 95%, 2Q24: 95%) after robust deposit gathering during the quarter (+10% YoY, +4% QoQ), though management observed a flight to fixed deposits, particularly from the community and corporate banking segments – the group’s CASA ratio dropped slightly to 28% from 31% in 1Q25 (2Q24: 26%). Management remains comfortable with its asset quality position, with GILs on an improving trend – the 2Q25 GIL ratio of 1.83% was down 6bps YoY (QoQ: -1bp). Liquidity and capital levels also held up well, with the 2Q25 LCR and CET-1 ratios at 171% and 13.4% respectively (1Q25: 168% and 13.5%).
- Briefing takeaways. Management plans to unveil revised FY25 guidance in its 3Q25 results briefing – early indications suggest there could be downgrades to loans growth and ROE guidance, which were last set at 12% and 6% respectively. Elsewhere, while the corporate banking segment dipped 3% YoY, management is optimistic of prospects ahead as it has a solid MYR13bn pipeline across multiple thematic sectors. Additionally, management expects chunky Sarawak infrastructure-related deals to materialise in 2H25. Lastly, management is keen to pay out another share dividend in FY25F to preserve capital for growth, and this has received support from its largest shareholders.
- Only slight adjustments to earnings forecasts. Our TP is raised to MYR2.55, and includes an unchanged 4% ESG premium.
Forecasts and Valuation
Dec-23 | Dec-24 | Dec-25F | Dec-26F | Dec-27F | |
---|---|---|---|---|---|
Reported net profit (MYRm) | 402 | 510 | 494 | 560 | 643 |
Net profit growth (%) | (65.9) | 26.7 | (3.0) | 13.4 | 14.8 |
Recurring net profit (MYRm) | 402 | 510 | 494 | 560 | 643 |
Recurring EPS (MYR) | 0.16 | 0.20 | 0.20 | 0.22 | 0.25 |
BVPS (MYR) | 4.38 | 4.58 | 4.83 | 5.02 | 5.24 |
DPS (MYR) | 0.06 | na | 0.08 | 0.09 | 0.10 |
Recurring P/E (x) | 15.12 | 11.93 | 12.30 | 10.85 | 9.46 |
P/B (x) | 0.55 | 0.52 | 0.50 | 0.48 | 0.46 |
Dividend Yield (%) | 2.4 | na | 3.3 | 3.7 | 4.2 |
Return on average equity (%) | 3.7 | 4.5 | 4.1 | 4.5 | 4.9 |
Overall ESG Score: 3.2 (out of 4)
E Score: 2.8 (GOOD)
S Score: 3.5 (EXCELLENT)
G Score: 3.8 (EXCELLENT)
Please refer to the ESG analysis on the next page
Source: Company data, RHB
See important disclosures at the end of this report
Emissions And ESG
Trend analysis
Affin’s Scope 1 and 2 operational emissions posted a 36% decline in FY24. This was aided by the purchase of renewable energy certificates, which allowed c.5ktCO2e of emissions to be offset.
Emissions (tCO2e)
Dec-22 | Dec-23 | Dec-24 | Dec-25 | |
---|---|---|---|---|
Scope 1 | 19 | 19 | 43 | na |
Scope 2 | 18,302 | 17,593 | 11,253 | na |
Scope 3 | na | 7,904 | 8,241 | na |
Total emissions | 18,321 | 25,516 | 19,537 | na |
Source: Company data, RHB
Latest ESG-Related Developments
- Inclusion in ESG index: Affin was recently included in the FTSE4Good Bursa Malaysia Index, a global benchmark comprising of companies with exemplary ESG performance.
- Expanding electric vehicle (EV) financing infrastructure: Affin announced a partnership with Auto Bavaria to expand country-wide EV charging infrastructure, beginning with eight charging stations in Menara Affin, Tun Razak Exchange.
- Solar panel financing for homeowners: Affin recently launched its Solar Financing-l product to assist homeowners with transitioning to solar powered electricity for domestic use, and the bank has also partnered with 14 solar panel providers under this initiative.
ESG Unbundled
Overall ESG Score: 3.2 (out of 4)
Last Updated: 13 Feb 2025
E Score: 2.8 (GOOD)
Affin’s total emissions recorded a 28% YoY decrease in FY24, partly helped by offsets from renewable energy certificates. In its FY24 annual report, the group began disclosing full operational emissions disclosures alongside financed emissions indicators.
S Score: 3.5 (EXCELLENT)
Affin’s financial inclusion initiatives include several programmes to help eligible low-income entrepreneurs and military veterans to establish sustainable income streams. The bank is also fairly diverse (50-60% of employees are women), and employees receive a decent 59 hours of training pa on average.
G Score: 3.8 (EXCELLENT)
We do not note any material involvement from the bank in major corruption, money-laundering or terrorism financing cases over the past 10 years. Additionally, board members and senior management are subject to ESG-linked key performance indicators.
ESG Rating History
Chart description: ESG Rating trends from Aug-23 to Aug-25, showing scores around 2.9 to 3.2.
Source: RHB
See important disclosures at the end of this report
Financial Exhibits
Valuation basis
Our GGM assumptions are:
- COE of 9.3%;
- ROE assumption of 6.3%; and
- 3.5% long-term growth.
Key drivers
Our FY25F earnings are most sensitive to changes in:
- Net interest margin;
- Credit costs; and
- Non-interest income.
Key risks
The downside risks include:
- Softer-than-expected NIM expansion;
- Higher-than-expected credit costs; and
- Weaker-than-expected non-II.
The converse represents upside risks.
Company Profile
The principal activities of Affin are commercial banking and hire purchase, Islamic banking, investment banking and stock-broking, and money-broking. The group is also involved in life and general insurance via its jointly controlled entity/associate.
Financial summary (MYR)
Dec-23 | Dec-24 | Dec-25F | Dec-26F | Dec-27F | |
---|---|---|---|---|---|
EPS | 0.16 | 0.20 | 0.20 | 0.22 | 0.25 |
Recurring EPS | 0.16 | 0.20 | 0.20 | 0.22 | 0.25 |
DPS | 0.06 | na | 0.08 | 0.09 | 0.10 |
BVPS | 4.38 | 4.58 | 4.83 | 5.02 | 5.24 |
Valuation metrics
Dec-23 | Dec-24 | Dec-25F | Dec-26F | Dec-27F | |
---|---|---|---|---|---|
Recurring P/E (x) | 15.12 | 11.93 | 12.30 | 10.85 | 9.46 |
P/B (x) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
Dividend Yield (%) | 2.4 | na | 3.3 | 3.7 | 4.2 |
Income statement (MYRm)
Dec-23 | Dec-24 | Dec-25F | Dec-26F | Dec-27F | |
---|---|---|---|---|---|
Interest income | 4,387 | 5,034 | 5,094 | 5,403 | 5,792 |
Interest expense | (3,008) | (3,517) | (3,401) | (3,545) | (3,781) |
Net interest income | 1,379 | 1,518 | 1,692 | 1,859 | 2,012 |
Non interest income | 607 | 652 | 674 | 708 | 757 |
Total operating income | 1,986 | 2,170 | 2,366 | 2,567 | 2,768 |
Overheads | (1,421) | (1,668) | (1,739) | (1,820) | (1,904) |
Pre-provision operating profit | 565 | 502 | 627 | 747 | 864 |
Loan impairment allowances | (75) | 170 | (64) | (98) | (111) |
Other impairment allowances | (3) | (19) | (2) | (2) | (2) |
Income from associates | 36 | 55 | 90 | 90 | 95 |
Pre-tax profit | 523 | 708 | 650 | 737 | 846 |
Taxation | (121) | (198) | (156) | (177) | (203) |
Reported net profit | 402 | 510 | 494 | 560 | 643 |
Recurring net profit | 402 | 510 | 494 | 560 | 643 |
Profitability ratios
Dec-23 | Dec-24 | Dec-25F | Dec-26F | Dec-27F | |
---|---|---|---|---|---|
Return on average assets (%) | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 |
Return on average equity (%) | 3.7 | 4.5 | 4.1 | 4.5 | 4.9 |
Return on IEAs (%) | 4.8 | 4.9 | 4.7 | 4.8 | 4.8 |
Cost of funds (%) | 3.6 | 3.7 | 3.4 | 3.4 | 3.4 |
Net interest spread (%) | 1.2 | 1.2 | 1.3 | 1.4 | 1.4 |
Net interest margin (%) | 1.5 | 1.5 | 1.6 | 1.6 | 1.7 |
Non-interest income / total income (%) | 30.6 | 30.1 | 28.5 | 27.6 | 27.3 |
Cost to income ratio (%) | 71.6 | 76.9 | 73.5 | 70.9 | 68.8 |
Credit cost (bps) | 12.2 | (25.0) | 8.9 | 12.8 | 13.4 |
Balance sheet (MYRm)
Dec-23 | Dec-24 | Dec-25F | Dec-26F | Dec-27F | |
---|---|---|---|---|---|
Total gross loans | 65,225 | 70,892 | 73,662 | 79,494 | 85,792 |
Other interest earning assets | 34,193 | 34,759 | 36,046 | 37,338 | 38,688 |
Total gross IEAS | 99,418 | 105,651 | 109,708 | 116,832 | 124,480 |
Total provisions | (1,438) | (1,153) | (1,285) | (1,449) | (1,625) |
Net loans to customers | 63,787 | 69,740 | 72,377 | 78,045 | 84,167 |
Total net IEAS | 97,980 | 104,498 | 108,423 | 115,383 | 122,855 |
Total non-IEAS | 7,268 | 7,344 | 8,410 | 7,857 | 7,211 |
Total assets | 105,248 | 111,842 | 116,833 | 123,240 | 130,066 |
Customer deposits | 70,834 | 73,744 | 82,593 | 87,548 | 92,801 |
Other interest-bearing liabilities | 21,288 | 23,111 | 19,279 | 20,142 | 21,063 |
Total IBLs | 92,122 | 96,855 | 101,872 | 107,691 | 113,864 |
Total non-IBLs | 2,017 | 3,386 | 2,731 | 2,820 | 2,913 |
Total liabilities | 94,139 | 100,241 | 104,603 | 110,511 | 116,777 |
Share capital | 5,371 | 5,489 | 5,626 | 5,766 | 5,911 |
Shareholders’ equity | 11,109 | 11,601 | 12,229 | 12,729 | 13,289 |
Asset quality and capital
Dec-23 | Dec-24 | Dec-25F | Dec-26F | Dec-27F | |
---|---|---|---|---|---|
Reported NPLs/gross cust loans (%) | 1.9 | 2.0 | 1.9 | 1.8 | 1.8 |
Total provisions / reported NPLs (%) | 113.6 | 82.4 | 92.7 | 99.4 | 103.3 |
Source: Company data, RHB
See important disclosures at the end of this report
Results At a Glance
Figure 1: Affin – summary of 2Q25 and 1H25 results
FYE Dec (MYRm) | 2Q24 | 1Q25 | 2Q25 | QoQ (%) | YoY (%) | 1H24 | 1H25 | YoY (%) | Comments |
---|---|---|---|---|---|---|---|---|---|
NII (+ Islamic Banking) | 353 | 404 | 432 | 7 | 22 | 715 | 835 | 17 | Largely driven by the 7% YoY loans growth, while reported NIM also saw a 5bps uptick |
NIM (%) – reported | 1.40 | 1.47 | 1.48 | 1.44 | 1.49 | ||||
Non-II | 142 | 140 | 185 | 32 | 30 | 284 | 325 | 14 | Of this, core fee income shrank 18% YoY, but offset by higher investment and forex gains |
Non-II/Total income (%) | 28.6 | 25.8 | 30.0 | 28.4 | 28.0 | ||||
Operating income | 495 | 544 | 616 | 13 | 25 | 999 | 1,160 | 16 | |
Overhead expenses | (368) | (379) | (420) | 11 | 14 | (747) | (799) | 7 | Sequential cost increase in 2Q25 was largely a result of higher personnel expenses (bonus accruals) and IT spend |
CIR (%) | 74.3 | 69.7 | 68.2 | 74.7 | 68.9 | ||||
PIOP | 127 | 165 | 196 | 19 | 54 | 253 | 361 | 43 | |
Impairments on financial assets | 2 | 0 | (6) | >100 | >100 | (3) | (6) | >100 | |
Impairments on loans | 11 | (9) | (34) | >100 | >100 | 34 | (43) | >100 | |
Annualised credit cost (bps)* | (6) | 5 | 19 | (12) | 14 | ||||
Operating profit | 139 | 156 | 155 | (0) | 12 | 283 | 312 | 10 | |
Associates | 11 | 22 | 24 | 11 | >100 | 12 | 46 | >100 | |
Pretax profit | 151 | 178 | 180 | 1 | 19 | 296 | 358 | 21 | |
Tax | (32) | (54) | (36) | (33) | 13 | (67) | (90) | 35 | |
Effective tax rate (%) | 21.4 | 30.3 | 20.2 | 22.6 | 25.3 | ||||
Minorities | 0 | 0 | 0 | 0 | 0 | ||||
Net profit | 119 | 124 | 143 | 16 | 21 | 229 | 268 | 17 | 54% and 47% of our and consensus FY25F |
Other key data and ratios
2Q24 | 1Q25 | 2Q25 | QoQ (%) | YoY (%) | Comments | ||||
---|---|---|---|---|---|---|---|---|---|
Gross loans | 69,016 | 72,898 | 74,066 | 2 | 7 | Driven by the higher-yielding consumer loan products, eg personal loans (+24% YoY, +4% QoQ). Enterprise banking also saw a strong 15% YoY uptick (QoQ: +4%) | |||
Customer deposits | 71,226 | 75,467 | 78,202 | 4 | 10 | Of these, CASA deposits grew 20% YoY (QoQ: -9%), while fixed and other deposits grew by a softer 6% YoY (QoQ: +10%). The CASA ratio in Jun 2025 stood at 28.2% (Dec 2024: 30.4%, Mar 2025: 32.2%) | |||
Gross impaired loans | 1,306 | 1,344 | 1,359 | 1 | 4 | ||||
Total assets | 108,166 | 116,180 | 117,037 | 1 | 8 | ||||
Shareholders’ funds | 11,303 | 11,773 | 12,000 | 2 | 6 | ||||
ROAA (%) | 0.46 | 0.46 | 0.52 | 0.47 | 0.51 | ||||
ROAE (%) | 4.21 | 4.25 | 4.83 | 4.15 | 4.63 | Below the target of 6%, which is now under review | |||
LDR (%) | 95.1 | 95.2 | 93.3 | ||||||
GIL ratio (%) | 1.89 | 1.84 | 1.83 | ||||||
Loan loss coverage (%) | 97.2 | 80.0 | 79.3 | Management retains c.MYR250m in overlay buffers | |||||
CET-1 ratio (%) | 12.8 | 13.5 | 13.4 |
Note: *Based on internally derived estimates
Source: Company data, RHB
See important disclosures at the end of this report
Management guidance
Figure 2: Affin – management guidance and financial targets for FY25
FYE Dec | FY24 achieved | FY25 targets* | 1H25 achieved | Comments |
---|---|---|---|---|
Reported ROE | 4.5% | 6.0% | 4.5% | Given the softer-than-guided 1H25 print, we believe management will likely revise its ROE guidance downward |
Reported NIM (adjusted) | 1.45% | 1.55% | 1.51% | Adjusted NIM includes income from liability management initiatives ie forex hedging. All else equal, management anticipates a minor 1.5bps HoH NIM compression in 2H25 from July’s OPR cut, though we think this should be mitigated by an improving asset mix (ie stronger enterprise banking growth) and CASA inflow (partly from Sarawak-related payroll accounts). Management also intends to keep its NIM guidance as is |
CIR | 74.6% | 65.0% | 68.9% | |
Loans growth | 8.1% | 12.0% | 7.3% | The slower-than-expected performance was largely attributable to a decline in the corporate banking segment, which saw lumpy repayments and slower drawdowns. The corporate banking pipeline for 2H25 stands at MYR13bn, which does not include potential sizeable loans for infrastructure projects in Sarawak. Nevertheless, management flagged a potential downgrade of its loans growth guidance for FY25 |
GIL | 1.94% | 1.70% | 1.83% | 2Q25 saw one corporate from the real estate sector slipping into impaired status. The community banking GIL ratio was sequentially stable, while the enterprise banking GIL ratio showed a QoQ improvement |
Note: *FY25 guidance is currently under review
Source: Company data, RHB
Earnings forecasts
Changes to our earnings estimates are as follows:
- A lower FY25 NIM assumption of 1.57% (from 1.60%), which implies a slower 9bps YoY expansion (previously +12bps). The slower NIM expansion reflects the OPR cut effect, though we think this can be mitigated by an improving asset mix and a higher CASA stock;
- Greater associate contributions from Generali Group;
- We still expect cash dividend payments from Affin for now, pending further clarity on its share dividend proposal. As such, risks to our DPS estimates are tilted towards zero cash dividends.
Figure 3: Affin – revisions to earnings forecasts
FYE Dec (MYRm) | Previous FY25F | Previous FY26F | Previous FY27F | Revised FY25F | Revised FY26F | New FY27F | % Change FY25F | % Change FY26F | % Change FY27F |
---|---|---|---|---|---|---|---|---|---|
Net interest income | 1,720 | 1,887 | 2,044 | 1,692 | 1,859 | 2,012 | -1.6% | -1.5% | -1.6% |
Non-interest income | 674 | 708 | 757 | 674 | 708 | 757 | 0.0% | 0.0% | 0.0% |
Operating expenses | (1,739) | (1,820) | (1,904) | (1,739) | (1,820) | (1,904) | 0.0% | 0.0% | 0.0% |
PIOP | 654 | 776 | 896 | 627 | 747 | 864 | -4.2% | -3.7% | -3.6% |
Impairment charges | (66) | (100) | (113) | (66) | (100) | (113) | 0.0% | 0.0% | 0.0% |
Pretax profit | 648 | 736 | 843 | 650 | 737 | 846 | 0.4% | 0.2% | 0.3% |
Net profit | 493 | 559 | 641 | 494 | 560 | 643 | 0.4% | 0.2% | 0.3% |
EPS (MYR) | 0.19 | 0.22 | 0.25 | 0.20 | 0.22 | 0.25 | 0.4% | 0.2% | 0.3% |
DPS (MYR) | 0.08 | 0.09 | 0.10 | 0.08 | 0.09 | 0.10 | 0.4% | 0.2% | 0.3% |
Loan growth (%) | 12.0 | 8.0 | 8.0 | 12.0 | 8.0 | 8.0 | |||
NIM (%) | 1.60 | 1.67 | 1.69 | 1.57 | 1.64 | 1.67 | |||
CIR (%) | 72.7 | 70.1 | 68.0 | 73.5 | 70.9 | 68.8 | |||
Credit cost (bps) | 9 | 13 | 13 | 9 | 13 | 13 |
Source: Company data, RHB
See important disclosures at the end of this report
Valuation and TP
We raise our TP to MYR2.55 (from MYR2.45), based on an unchanged GGM-derived 0.49x P/BV, ie 0.5SD below its long-term mean. The sole change to our GGM model was to the BVPS, which we rolled forward to FY26F.
As investor focus shifts to FY26F, our +13% FY26F earnings growth for Affin stands out, though softer-than-expected NIM expansion presents the key downside risk in our view. While sentiment towards risk assets appears to have improved as of late, we still prefer defensive, higher-yielding banks for now.
Figure 4: Affin – GGM valuation with ESG overlay
Cost of equity (COE) computation: | Sustainable ROE (%) | 6.3 | |
---|---|---|---|
Risk free rate (%) | 4.0 | COE (%) | 9.3 |
Equity premium (%) | 5.3 | Long-term growth (g) | 3.5 |
Beta (x) | 1.0 | Implied P/BV (x) | 0.49 |
Cost of equity – CAPM (%) | 9.3 | BVPS – FY26F | MYR5.02 |
Intrinsic value | MYR2.44 | ||
ESG premium/(discount) (%) | 4.0 | ESG premium/(discount) | MYR0.10 |
TP (rounded) | MYR2.55 |
Source: Company data, RHB
Figure 5: Affin’s 12-month forward consensus P/E
Chart description: Fwd P/E trend with Mean, +1SD, and -1SD lines from Jan-09 to Jan-25, showing values ranging from 7.2x to 18.0x.
Figure 6: Affin’s 12-month forward consensus P/BV
Chart description: Fwd P/BV trend with Mean, +1SD, and -1SD lines from Jan-09 to Jan-25, showing values ranging from 0.2x to 1.0x, along with ROE (RHS) from 0% to 12%.
Source: Bloomberg, RHB
See important disclosures at the end of this report
Recommendation Chart
Recommendation Table
Date | Recommendation | Target Price | Price |
---|---|---|---|
2025-05-19 | Neutral | 2.45 | 2.72 |
2025-04-29 | Neutral | 2.45 | 2.67 |
2025-03-26 | Neutral | 2.45 | 2.66 |
2025-02-12 | Sell | 2.25 | 2.64 |
2024-11-29 | Sell | 2.25 | 3.06 |
2024-09-25 | Sell | 1.60 | 3.08 |
2024-05-22 | Sell | 1.65 | 2.40 |
2024-03-22 | Sell | 1.65 | 2.40 |
2024-03-01 | Sell | 1.70 | 2.46 |
2024-02-23 | Sell | 1.90 | 2.47 |
2023-11-20 | Neutral | 1.90 | 1.89 |
2023-08-28 | Buy | 2.20 | 1.82 |
2023-05-29 | Buy | 2.30 | 1.98 |
2023-03-28 | Buy | 2.40 | 1.97 |
2022-11-29 | Buy | 2.80 | 2.35 |
Source: RHB, Bloomberg
See important disclosures at the end of this report
RHB Guide to Investment Ratings
Buy: Share price may exceed 10% over the next 12 months
Trading Buy: Share price may exceed 15% over the next 3 months, however longer-term outlook remains uncertain
Neutral: Share price may fall within the range of +/- 10% over the next 12 months
Take Profit: Target price has been attained. Look to accumulate at lower levels
Sell: Share price may fall by more than 10% over the next 12 months
Not Rated: Stock is not within regular research coverage
Investment Research Disclaimers
RHB has issued this report for information purposes only. This report is intended for circulation amongst RHB and its affiliates’ clients generally or such persons as may be deemed eligible by RHB to receive this report and does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this report. This report is not intended, and should not under any circumstances be construed as, an offer or a solicitation of an offer to buy or sell the securities referred to herein or any related financial instruments.
This report may further consist of, whether in whole or in part, summaries, research, compilations, extracts or analysis that has been prepared by RHB’s strategic, joint venture and/or business partners. No representation or warranty (express or implied) is given as to the accuracy or completeness of such information and accordingly investors should make their own informed decisions before relying on the same.
This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to the applicable laws or regulations. By accepting this report, the recipient hereof (i) represents and warrants that it is lawfully able to receive this document under the laws and regulations of the jurisdiction in which it is located or other applicable laws and (ii) acknowledges and agrees to be bound by the limitations contained herein. Any failure to comply with these limitations may constitute a violation of applicable laws.
All the information contained herein is based upon publicly available information and has been obtained from sources that RHB believes to be reliable and correct at the time of issue of this report. However, such sources have not been independently verified by RHB and/or its affiliates and this report does not purport to contain all information that a prospective investor may require. The opinions expressed herein are RHB’s present opinions only and are subject to change without prior notice. RHB is not under any obligation to update or keep current the information and opinions expressed herein or to provide the recipient with access to any additional information. Consequently, RHB does not guarantee, represent or warrant, expressly or impliedly, as to the adequacy, accuracy, reliability, fairness or completeness of the information and opinion contained in this report. Neither RHB (including its officers, directors, associates, connected parties, and/or employees) nor does any of its agents accept any liability for any direct, indirect or consequential losses, loss of profits and/or damages that may arise from the use or reliance of this research report and/or further communications given in relation to this report. Any such responsibility or liability is hereby expressly disclaimed.
Whilst every effort is made to ensure that statement of facts made in this report are accurate, all estimates, projections, forecasts, expressions of opinion and other subjective judgments contained in this report are based on assumptions considered to be reasonable and must not be construed as a representation that the matters referred to therein will occur. Different assumptions by RHB or any other source may yield substantially different results and recommendations contained on one type of research product may differ from recommendations contained in other types of research. The performance of currencies may affect the value of, or income from, the securities or any other financial instruments referenced in this report. Holders of depositary receipts backed by the securities discussed in this report assume currency risk. Past performance is not a guide to future performance. Income from investments may fluctuate. The price or value of the investments to which this report relates, either directly or indirectly, may fall or rise against the interest of investors.
This report may contain comments, estimates, projections, forecasts and expressions of opinion relating to macroeconomic research published by RHB economists of which should not be considered as investment ratings/advice and/or a recommendation by such economists on any securities discussed in this report.
This report does not purport to be comprehensive or to contain all the information that a prospective investor may need in order to make an investment decision. The recipient of this report is making its own independent assessment and decisions regarding any securities or financial instruments referenced herein. Any investment discussed or recommended in this report may be unsuitable for an investor depending on the investor’s specific investment objectives and financial position. The material in this report is general information intended for recipients who understand the risks of investing in financial instruments. This report does not take into account whether an investment or course of action and any associated risks are suitable for the recipient. Any recommendations contained in this report must therefore not be relied upon as investment advice based on the recipient’s personal circumstances. Investors should make their own independent evaluation of the information contained herein, consider their own investment objective, financial situation and particular needs and seek their own financial, business, legal, tax and other advice regarding the appropriateness of investing in any securities or the investment strategies discussed or recommended in this report.
This report may contain forward-looking statements which are often but not always identified by the use of words such as “believe”, “estimate”, “intend” and “expect” and statements that an event or result “may”, “will” or “might” occur or be achieved and other similar expressions. Such forward-looking statements are based on assumptions made and information currently available to RHB and are subject to known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievement to be materially different from any future results, performance or achievement, expressed or implied by such forward-looking statements. Caution should be taken with respect to such statements and recipients of this report should not place undue reliance on any such forward-looking statements. RHB expressly disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or circumstances after the date of this publication or to reflect the occurrence of unanticipated events.
The use of any website to access this report electronically is done at the recipient’s own risk, and it is the recipient’s sole responsibility to take precautions to ensure that it is free from viruses or other items of a destructive nature. This report may also provide the addresses of, or contain hyperlinks to, websites. RHB takes no responsibility for the content contained therein. Such addresses or hyperlinks (including addresses or hyperlinks to RHB own website material) are provided solely for the recipient’s convenience. The information and the content of the linked site do not in any way form part of this report. Accessing such website or following such link through the report or RHB website shall be at the recipient’s own risk.
This report may contain information obtained from third parties. Third party content providers do not guarantee the accuracy, completeness, timeliness or availability of any information and are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, or for the results obtained from the use of such content. Third party content providers give no express or implied warranties, including, but not limited to, any warranties of merchantability or fitness for a particular purpose or use. Third party content providers shall not be liable for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or profits and opportunity costs) in connection with any use of their content.
The research analysts responsible for the production of this report hereby certifies that the views expressed herein accurately and exclusively reflect his or her personal views and opinions about any and all of the issuers or securities analysed in this report and were prepared independently and autonomously. The research analysts that authored this report are precluded by RHB in all circumstances from trading in the securities or other financial instruments referenced in the report, or from having an interest in the company(ies) that they cover.
The contents of this report is strictly confidential and may not be copied, reproduced, published, distributed, transmitted or passed, in whole or in part, to any other person without the prior express written consent of RHB and/or its affiliates. This report has been delivered to RHB and its affiliates’ clients for information purposes only and upon the express understanding that such parties will use it only for the purposes set forth above. By electing to view or accepting a copy of this report, the recipients have agreed that they will not print, copy, videotape, record, hyperlink, download, or otherwise attempt to reproduce or re-transmit (in any form including hard copy or electronic distribution format) the contents of this report. RHB and/or its affiliates accepts no liability whatsoever for the actions of third parties in this respect.
The contents of this report are subject to copyright. Please refer to Restrictions on Distribution below for information regarding the distributors of this report. Recipients must not reproduce or disseminate any content or findings of this report without the express permission of RHB and the distributors.
The securities mentioned in this publication may not be eligible for sale in some states or countries or certain categories of investors. The recipient of this report should have regard to the laws of the recipient’s place of domicile when contemplating transactions in the securities or other financial instruments referred to herein. The securities discussed in this report may not have been registered in such jurisdiction. Without prejudice to the foregoing, the recipient is to note that additional disclaimers, warnings or qualifications may apply based on geographical location of the person or entity receiving this report.
The term “RHB” shall denote, where appropriate, the relevant entity distributing or disseminating the report in the particular jurisdiction referenced below, or, in every other case, RHB Investment Bank Berhad and its affiliates, subsidiaries and related companies.
RESTRICTIONS ON DISTRIBUTION
Malaysia
This report is issued and distributed in Malaysia by RHB Investment Bank Berhad (“RHBIB”). The views and opinions in this report are our own as of the date hereof and is subject to change. If the Financial Services and Markets Act of the United Kingdom or the rules of the Financial Conduct Authority apply to a recipient, our obligations owed to such recipient therein are unaffected. RHBIB has no obligation to update its opinion or the information in this report.
Indonesia
This report is issued and distributed in Indonesia by PT RHB Sekuritas Indonesia. This research does not constitute an offering document and it should not be construed as an offer of securities in Indonesia. Any securities offered or sold, directly or indirectly, in Indonesia or to any Indonesian citizen or corporation (wherever located) or to any Indonesian resident in a manner which constitutes a public offering under Indonesian laws and regulations must comply with the prevailing Indonesian laws and regulations.
Singapore
This report is issued and distributed in Singapore by RHB Bank Berhad (through its Singapore branch) which is an exempt capital markets services entity and an exempt financial adviser regulated by the Monetary Authority of Singapore. RHB Bank Berhad (through its Singapore branch) may distribute reports produced by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, RHB Bank Berhad (through its Singapore branch) accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact RHB Bank Berhad (through its Singapore branch) in respect of any matter arising from or in connection with the report.
United States
This report was prepared by RHB is meant for distribution solely and directly to “major” U.S. institutional investors as defined under, and pursuant to, the requirements of Rule 15a-6 under the U.S. Securities and Exchange Act of 1934, as amended (the “Exchange Act”) via a registered U.S. broker-dealer as appointed by RHB from time to time. Accordingly, any access to this report via Bursa Marketplace or any other Electronic Services Provider is not intended for any party other than “major” US institutional investors (via a registered U.S broker-dealer), nor shall be deemed as solicitation by RHB in any manner. RHB is not registered as a broker-dealer in the United States and currently has not appointed a U.S. broker-dealer. Additionally, RHB does not offer brokerage services to U.S. persons. Any order for the purchase or sale of all securities discussed herein must be placed with and through a registered U.S. broker-dealer as appointed by RHB from time to time as required by the Exchange Act Rule 15a-6. For avoidance of doubt, RHB reiterates that it has not appointed any U.S. broker-dealer during the issuance of this report. This report is confidential and not intended for distribution to, or use by, persons other than the recipient and its employees, agents and advisors, as applicable. Additionally, where research is distributed via Electronic Service Provider, the analysts whose names appear in this report are not registered or qualified as research analysts in the United States and are not associated persons of any registered U.S. broker-dealer as appointed by RHB from time to time and therefore may not be subject to any applicable restrictions under Financial Industry Regulatory Authority (“FINRA”) rules on communications with a subject company, public appearances and personal trading. Investing in any non-U.S. securities or related financial instruments discussed in this research report may present certain risks. The securities of non-U.S. issuers may not be registered with, or be subject to the regulations of, the U.S. Securities and Exchange Commission. Information on non-U.S. securities or related financial instruments may be limited. Foreign companies may not be subject to audit and reporting standards and regulatory requirements comparable to those in the United States. The financial instruments discussed in this report may not be suitable for all investors. Transactions in foreign markets may be subject to regulations that differ from or offer less protection than those in the United States.
DISCLOSURE OF CONFLICTS OF INTEREST
RHB Investment Bank Berhad, its subsidiaries (including its regional offices) and associated companies, (“RHBIB Group”) form a diversified financial group, undertaking various investment banking activities which include, amongst others, underwriting, securities trading, market making and corporate finance advisory.
As a result of the same, in the ordinary course of its business, any member of the RHBIB Group, may, from time to time, have business relationships with, hold any positions in the securities and/or capital market products (including but not limited to shares, warrants, and/or derivatives), trade or otherwise effect transactions for its own account or the account of its customers or perform and/or solicit investment, advisory or other services from any of the subject company(ies) covered in this research report.
While the RHBIB Group will ensure that there are sufficient information barriers and internal controls in place where necessary, to prevent/manage any conflicts of interest to ensure the independence of this report, investors should also be aware that such conflict of interest may exist in view of the investment banking activities undertaken by the RHBIB Group as mentioned above and should exercise their own judgement before making any investment decisions.
In Singapore, investment research activities are conducted under RHB Bank Berhad (through its Singapore branch), and the disclaimers above similarly apply.
Malaysia
Save as disclosed in the following link RHB Research Conflict Disclosures Aug 2025 and to the best of our knowledge, RHBIB hereby declares that:
- RHBIB does not have a financial interest in the securities or other capital market products of the subject company(ies) covered in this report.
- RHBIB is not a market maker in the securities or capital market products of the subject company(ies) covered in this report.
- None of RHBIB’s staff or associated person serve as a director or board member* of the subject company(ies) covered in this report
*For the avoidance of doubt, the confirmation is only limited to the staff of research department - RHBIB did not receive compensation for investment banking or corporate finance services from the subject company in the past 12 months.
- RHBIB did not receive compensation or benefit (including gift and special cost arrangement e.g. company/issuer-sponsored and paid trip) in relation to the production of this report.
Indonesia
Save as disclosed in the following link RHB Research Conflict Disclosures Aug 2025 and to the best of our knowledge, PT RHB Sekuritas Indonesia hereby declares that:
- PT RHB Sekuritas Indonesia and its investment analysts, does not have any interest in the securities of the subject company(ies) covered in this report.
- PT RHB Sekuritas Indonesia is not a market maker in the securities or capital market products of the subject company(ies) covered in this report.
- None of PT RHB Sekuritas Indonesia’s staff** or associated person serve as a director or board member* of the subject company(ies) covered in this report.
- PT RHB Sekuritas Indonesia did not receive compensation for investment banking or corporate finance services from the subject company in the past 12 months.
- PT RHB Sekuritas Indonesia** did not receive compensation or benefit (including gift and special cost arrangement e.g. company/issuer-sponsored and paid trip) in relation to the production of this report:
For the avoidance of doubt, interest in securities include the following:
a) Holding directly or indirectly, individually or jointly own/hold securities or entitled for dividends, interest or proceeds from the sale or exercise of the subject company’s securities covered in this report*;
b) Being bound by an agreement to purchase securities or has the right to transfer the securities or has the right to pre subscribe the securities*.
c) Being bound or required to buy the remaining securities that are not subscribed/placed out pursuant to an Initial Public Offering*.
d) Managing or jointly with other parties managing such parties as referred to in (a), (b) or (c) above.
Notes:
*The overall disclosure is limited to information pertaining to PT RHB Sekuritas Indonesia only.
**The disclosure is limited to Research staff of PT RHB Sekuritas Indonesia only.
Singapore
Save as disclosed in the following link RHB Research Conflict Disclosures Aug 2025 and to the best of our knowledge, the Singapore Research department of RHB Bank Berhad (through its Singapore branch) hereby declares that:
- RHB Bank Berhad, its subsidiaries and/or associated companies do not make a market in any issuer covered by the Singapore research analysts in this report.
- RHB Bank Berhad, its subsidiaries and/or its associated companies and its analysts do not have a financial interest (including a shareholding of 1% or more) in the issuer covered by the Singapore research analysts in this report.
- RHB Bank Berhad’s Singapore research staff or connected persons do not serve on the board or trustee positions of the issuer covered by the Singapore research analysts in this report.
- RHB Bank Berhad, its subsidiaries and/or its associated companies do not have and have not within the last 12 months had any corporate finance advisory relationship with the issuer covered by the Singapore research analysts in this report or any other relationship that may create a potential conflict of interest.
- RHB Bank Berhad, or person associated or connected to it do not have any interest in the acquisition or disposal of, the securities, specified securities based derivatives contracts or units in a collective investment scheme covered by the Singapore research analysts in this report.
- RHB Bank Berhad’s Singapore research analysts do not receive any compensation or benefit in connection with the production of this research report or recommendation on the issuer covered by the Singapore research analysts.
Analyst Certification
The analyst(s) who prepared this report, and their associates hereby, certify that:
(1) they do not have any financial interest in the securities or other capital market products of the subject companies mentioned in this report, except for:
Analyst | Company |
---|---|
(2) no part of his or her compensation was, is or will be directly or indirectly related to the specific recommendations or views expressed in this report.
KUALA LUMPUR
RHB Investment Bank Bhd
Level 3A, Tower One, RHB Centre
Jalan Tun Razak
Kuala Lumpur 50400
Malaysia
Tel: +603 2302 8100
Fax: +603 2302 8134
JAKARTA
PT RHB Sekuritas Indonesia
Revenue Tower, 11th Floor, District 8 – SCBD
Jl. Jendral Sudirman Kav 52-53
Jakarta 12190
Indonesia
Tel: +6221 5093 9888
Fax: +6221 5093 9777
SINGAPORE
RHB Bank Berhad (Singapore branch)
90 Cecil Street
#04-00 RHB Bank Building
Singapore 069531
Fax: +65 6509 0470